Literature DB >> 25201764

Impaired in-vitro responses to IL-12 and IFN-γ in Iranian patients with Mendelian susceptibility to mycobacterial disease.

N Parvaneh1, B Pourakbari2, N Rezaei3, A Omidvar2, F Sabouni4, S Mahmoudi2, G Khotaei4, S Mamishi5.   

Abstract

INTRODUCTION: Diagnosis of specific molecular defects of Mendelian susceptibility to mycobacterial diseases (MSMD) patients is important with respect to their clinical outcomes and their response to therapy. The aim of this study was to perform functional tests on blood samples of a group of patients who were suspected of having MSMD.
METHODS: This study was performed on 11 cases who had mycobacterial infections and suspected MSMD. Whole blood cell culture was performed in presence of different stimulators. The supernatants were assayed for IFN-γ, IL-12p40 by ELISA method.
RESULTS: All patients presented with complications of BCG vaccine in the form of localised lymphadenitis or disseminated BCG infection and chronic mycobacterial osteomyelitis. Infections with Salmonella species occurred in two patients. In-vitro studies showed that 10 cases had impaired response to IL-12. However, the baseline levels of IL-12p40 were normal, while one of our patients may have a potential IFN-γ signalling defect or an IL-12p40 defect.
CONCLUSIONS: Early detection of MSMD and commencing of appropriate combination therapy could prevent severe or even fatal complications of uncontrolled mycobacterial infections.
Copyright © 2014 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Immunodeficiency; Mendelian susceptibility to mycobacterial diseases; Mycobacterial diseases

Mesh:

Substances:

Year:  2014        PMID: 25201764     DOI: 10.1016/j.aller.2014.05.008

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  5 in total

Review 1.  Pediatric tuberculosis in Iran: a review of 10-years study in an Iranian referral hospital.

Authors:  Zahra Movahedi; Shima Mahmoudi; Maryam Banar; Babak Pourakbari; Alireza Aziz-Ahari; Amitis Ramezani; Setareh Mamishi
Journal:  Acta Biomed       Date:  2022-05-11

2.  Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.

Authors:  Shima Mahmoudi; Saeid Khaheshi; Babak Pourakbari; Asghar Aghamohammadi; Sepideh Keshavarz Valian; Abbas Bahador; Farah Sabouni; Amitis Ramezani; Setareh Mamishi
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Susceptibility to mycobacterial disease due to mutations in IL-12Rβ1 in three Iranian patients.

Authors:  Maryam Alinejad Dizaj; Esmaeil Mortaz; Seyed Alireza Mahdaviani; Davood Mansouri; Payam Mehrian; Els M Verhard; Mohammad Varahram; Delara Babaie; Ian M Adcock; Johan Garssen; Esther van de Vosse; Aliakbar Velayati
Journal:  Immunogenetics       Date:  2017-12-18       Impact factor: 2.846

4.  Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.

Authors:  Ansia van Coller; Brigitte Glanzmann; Helena Cornelissen; Marlo Möller; Craig Kinnear; Monika Esser; Richard Glashoff
Journal:  BMC Immunol       Date:  2021-09-13       Impact factor: 3.615

5.  Interferon-gamma-dependent Immunity in Bacillus Calmette-Guérin Vaccine Osteitis Survivors.

Authors:  Laura Pöyhönen; Liisa Kröger; Heini Huhtala; Johanna Mäkinen; Jussi Mertsola; Ruben Martinez-Barricarte; Jean-Laurent Casanova; Jacinta Bustamante; Qiushui He; Matti Korppi
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.